Drug Design

Program Area Leader

Rui Moreira

PhD (1991) in Pharmaceutical Chemistry, Universidade de Lisboa
Full Professor, Pharmaceutical Chemistry and Therapeutics, Faculdade de Farmácia, Universidade de Lisboa
Group Leader, Medicinal Chemistry at iMed.ULisboa

The Program

Translating key findings of drug discovery into therapeutic strategies requires selective and effective chemical probes with potential for diagnostic and therapeutic applications. Focus is on tackling important biological problems using approaches ranging from in silico screening of chemical libraries to the development of bio-inspired, efficient and sustainable synthetic methodologies. In addition, natural products, biologicals and biotechnology-derived therapeutics are at the forefront of innovative drug development to address a variety of unmet medical needs. Development of therapeutic proteins and non-coding RNAs is set to have a major impact on health care, is likely to grow in the future and is at the centre of intense research in this program area.


Research Groups